메뉴 건너뛰기




Volumn 43, Issue 11, 2003, Pages 802-804

Critical illness polyneuropathy and myopathy

Author keywords

Critical illness myopathy (CIM); Critical illness polyneuropathy (CIP); Intensive care unit (ICU); Systemic inflammatory response syndrome (SIRS)

Indexed keywords

CORTICOSTEROID; NEUROMUSCULAR BLOCKING AGENT;

EID: 3042552734     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (5)

References (10)
  • 2
    • 3042549460 scopus 로고    scopus 로고
    • Japanese source
  • 3
    • 0022654953 scopus 로고
    • Critically ill polyneuropathy: Electrophysiological studies and differentiation from Guillain-Barre syndrome
    • Bolton CF, Laverty DA, Brown JD, et al: Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1986; 49: 563-573
    • (1986) J Neurol Neurosurg Psychiatry , vol.49 , pp. 563-573
    • Bolton, C.F.1    Laverty, D.A.2    Brown, J.D.3
  • 4
    • 0028103007 scopus 로고
    • Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy
    • Wijdicks EF, Fulgham JR: Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. Muscle Nerve 1994; 17: 1494-1495
    • (1994) Muscle Nerve , vol.17 , pp. 1494-1495
    • Wijdicks, E.F.1    Fulgham, J.R.2
  • 5
    • 0030712913 scopus 로고    scopus 로고
    • Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis
    • Mohr M, Englisch L, Roth A, et al: Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 1997; 23: 1144-1149
    • (1997) Intensive Care Med , vol.23 , pp. 1144-1149
    • Mohr, M.1    Englisch, L.2    Roth, A.3
  • 6
    • 0025225333 scopus 로고
    • Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
    • Ohlsson K, Bjork P, Bergenfeldt M, et al: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550-552
    • (1990) Nature , vol.348 , pp. 550-552
    • Ohlsson, K.1    Bjork, P.2    Bergenfeldt, M.3
  • 7
    • 0036198392 scopus 로고    scopus 로고
    • Clinical outcomes of critical illness polyneuropathy
    • Kane SL, Dasta JF: Clinical outcomes of critical illness polyneuropathy. Pharmacotherapy 2002; 22: 373-379
    • (2002) Pharmacotherapy , vol.22 , pp. 373-379
    • Kane, S.L.1    Dasta, J.F.2
  • 8
    • 0032078713 scopus 로고    scopus 로고
    • Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents
    • Deconinck N, Van Parijs V, Beckers-Bleukx G, et al: Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 1998; 8: 186-192
    • (1998) Neuromuscul Disord , vol.8 , pp. 186-192
    • Deconinck, N.1    Van Parijs, V.2    Beckers-Bleukx, G.3
  • 9
    • 3042598299 scopus 로고    scopus 로고
    • Japanese source
  • 10
    • 0034961811 scopus 로고    scopus 로고
    • Sodium channel inactivation in an animal model of acute quadriplegic myopathy
    • Rich MM, Pinter MJ: Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001; 50: 26-33
    • (2001) Ann Neurol , vol.50 , pp. 26-33
    • Rich, M.M.1    Pinter, M.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.